RECENTIN
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RECENTIN, covering 2012-10-30 to 2012-10-30. Get the full timeline:
Most recent: Clinical Trial Update: Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer [Phase 3]